Clinical Trial Update: GDF 15 in Sickle Cell Disease and Hereditary Spherocytosis

View source ↗

Summary

Clinical trial update concerning growth differentiation factor 15 (GDF15) in sickle cell disease and hereditary spherocytosis, with listed conditions including …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Dyserythropoietic Anemia Type
• Hereditary Spherocytosis
• Sickle Cell Disease
• Thalassemia Intermedia

Snippet

Sponsor: Wolfson Medical Center | Conditions: Patients With Thalassemia Intermedia,, Congenital Dyserythropoietic Anemia Type I | Status: UNKNOWN